Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs

被引:31
|
作者
Winograd, Rachel P. [1 ]
Wood, Claire A. [1 ]
Stringfellow, Erin J. [1 ]
Presnall, Ned [2 ]
Duello, Alex [1 ]
Horn, Phil [1 ]
Rudder, Tim [3 ]
机构
[1] Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle Dr, St Louis, MO 63134 USA
[2] Washington Univ, Dept Psychiat, 1 Brookings Dr, St Louis, MO 63130 USA
[3] Missouri Dept Mental Hlth, 1706 East Elm St, Jefferson City, MO 65101 USA
关键词
Opioid use disorder; Buprenorphine; Substance use treatment; State targeted response; LONG-TERM OUTCOMES; ASSISTED TREATMENT; BUPRENORPHINE TREATMENT; MAINTENANCE THERAPY; COUNSELOR ATTITUDES; UNITED-STATES; CARE; DEPENDENCE; BARRIERS; DISCONTINUATION;
D O I
10.1016/j.jsat.2019.06.015
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Leaders of Missouri's State Targeted Response to the opioid crisis (STR) grant have prioritized increasing access to treatment medications for opioid use disorder (MOUD) through a "Medication First" approach. This conceptual framework prioritizes rapid, sustained, low-barrier access to MOUD for optimal impact on decreased illicit drug use and mortality. Medication First principles and practices were facilitated through state-level structural changes and disseminated to participating community treatment programs via a multi-pronged, multi-disciplinary approach. In the first nine months of STR, 14 state-contracted treatment agencies operating 38 sites used STR funding to implement the Medication First model. Methods: We utilized state billing and service data to make comparisons before and during STR on the following outcomes: MOUD utilization, timely access to MOUD, amount of psychosocial services delivered, treatment retention at 1, 3, and 6 months, and monthly price of treatment. We conducted follow-up analyses examining differences across MOUD types (no medication, methadone, buprenorphine, oral naltrexone, mixed antagonist + agonist, and extended release naltrexone). Results: During STR, MOUD utilization increased (44.8% to 85.3%), timeliness of MOUD receipt improved (Median of 8 days vs. 0 days), there were fewer psychosocial services delivered, treatment retention improved at one, three, and six month timeframes, and the median cost per month was 21% lower than in the year prior to STR. All differences were driven by increased utilization of buprenorphine. Conclusions: Findings suggest Medication First implementation through STR was successful in all targeted domains. Though much more work is needed to further reduce logistical, financial, and cultural barriers to improved access to maintenance MOUD, the steps taken through Missouri's STR grant show significant promise at making swift and drastic transformations to a system of care in response to a growing public health emergency.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 50 条
  • [41] Medication Treatment for Opioid Use Disorder Reduces Suicide Risk
    Mooney, Larissa J.
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (04): : 262 - 263
  • [42] CHARACTERISTICS OF YOUTH RECEIVING MEDICATION TREATMENT FOR OPIOID USE DISORDER
    Bell, Lauren A.
    Dir, Ally L.
    Tu, Wanzhu
    Aalsma, Matthew C.
    JOURNAL OF ADOLESCENT HEALTH, 2021, 68 (02) : S46 - S46
  • [43] Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder
    Bagley, Sarah M.
    Hadland, Scott E.
    Carney, Brittany L.
    Saitz, Richard
    JOURNAL OF ADDICTION MEDICINE, 2017, 11 (06) : 415 - 416
  • [44] The NP and medication-assisted treatment for opioid use disorder
    Warner, Shirley A.
    Strickland, Daniel M.
    NURSE PRACTITIONER, 2022, 47 (07): : 10 - 13
  • [45] Addressing Workforce Needs for Medication Treatment of Opioid Use Disorder
    Thomas, Cindy Parks
    JOURNAL OF ADDICTION MEDICINE, 2019, 13 (01) : 1 - 2
  • [46] Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder
    Feder, Kenneth A.
    Krawczyk, Noa
    Saloner, Brendan
    JOURNAL OF ADOLESCENT HEALTH, 2017, 60 (06) : 747 - 750
  • [47] Homelessness and publicly funded substance use disorder treatment in California, 2016-2019: Analysis of treatment needs, level of care placement, and outcomes
    Padwa, Howard
    Bass, Brittany
    Urada, Darren
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 137
  • [48] Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative
    Radmall, Ashley O.
    Calder, Spencer
    Codell, Nodira
    Kelley, Alan Taylor
    Hawkins, Eric
    Jones, Audrey L.
    Hagedorn, Hildi J.
    Reynolds, Mary Anne
    Gordon, Adam J.
    JOURNAL OF ADDICTIONS NURSING, 2022, 33 (02) : 70 - 79
  • [49] Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers
    Bride, Brian E.
    Abraham, Amanda J.
    Roman, Paul M.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2011, 40 (01) : 87 - 94
  • [50] DELAY IN ACCESSING FIRST TREATMENT FOR OPIOID USE DISORDER
    Garcia-Page, R.
    Rodriguez-Minchole, M.
    Ortega-Muela, C.
    Pulido, J.
    Belza, M. J.
    Indave, B. I.
    Sarasa-Renedo, A.
    Sordo, L.
    GACETA SANITARIA, 2023, 37 : S180 - S180